Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia. (2022)

First Author: Burley TA
Attributed to:  Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14071600

PubMed Identifier: 35406371

Publication URI: http://europepmc.org/abstract/MED/35406371

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 7

ISSN: 2072-6694